Can GLP-1 Weight Loss Medication Help Teenagers with Obesity?

GLP-1 weight loss medicines have changed the way obesity is treated in adults, with treatments such as Wegovy® helping many people reduce appetite, lose weight and improve obesity-related health risks.

But can these medicines also help teenagers?

For some adolescents aged 12 years and over who are living with obesity, the answer may be yes.

However, prescription weight loss treatment for teenagers is very different from routine adult weight management. Adolescents are still growing physically and emotionally, so treatment needs to consider much more than weight alone.

A specialist assessment should take into account:

• age;

• height and weight;

• BMI relative to age and sex;

• growth and puberty;

• physical health;

• obesity-related medical conditions;

• psychological wellbeing;

• eating behaviour;

• previous weight-management support;

• nutrition;

• and family circumstances.

Certain GLP-1 medicines can be used in appropriately selected adolescents, but medication should always form part of a broader programme involving healthy nutrition, physical activity and ongoing clinical monitoring.

In this guide, we explain how GLP-1 weight loss medication works in teenagers, who may be eligible, what results may be possible, the correct Wegovy dosing schedule for adolescents and how specialist support from 24 HR Pharmacy may help eligible young people and their families.

What Are GLP-1 Weight Loss Medicines?

GLP-1 stands for glucagon-like peptide-1.

It is a naturally occurring hormone produced by the digestive system after eating.

GLP-1 helps regulate:

• appetite;

• feelings of fullness;

• food intake;

• blood glucose;

• and digestion.

GLP-1 receptor agonist medicines mimic some of the effects of this natural hormone.

For people living with obesity, they can make it easier to eat less by helping them feel fuller sooner and reducing persistent hunger and food cravings.

One of the best-known GLP-1 medicines is Wegovy® (semaglutide).

How Do GLP-1 Medicines Help With Weight Loss?

GLP-1 medicines act on areas of the brain involved in appetite regulation.

For some patients, this can lead to:

• less hunger between meals;

• smaller portion sizes;

• reduced cravings;

• feeling satisfied for longer after eating;

• and lower overall calorie intake.

They also slow aspects of digestion, which can contribute to prolonged feelings of fullness.

However, GLP-1 treatment does not simply “burn fat”.

Weight loss generally occurs because appetite regulation makes it easier to maintain healthier eating patterns and a reduced overall energy intake.

This is why medication is normally used alongside improvements to diet and physical activity rather than as a replacement for them.

Can Teenagers Use GLP-1 Medication?

Some GLP-1 medicines are licensed for use in selected adolescents.

In the UK, injectable Wegovy® (semaglutide) is licensed for weight management in adolescents aged 12 years and over who meet the relevant criteria.

The current UK product information states that Wegovy may be used in adolescents aged 12+ who have:

• obesity, defined using age- and sex-specific BMI growth charts; and

• a body weight above 60 kg.

It is used alongside a reduced-calorie diet and increased physical activity.

This does not mean that every teenager aged 12 or over with excess weight should receive medication.

A clinician must determine whether treatment is appropriate.

Why Is Teenage Obesity Treated Differently From Adult Obesity?

Adults are commonly assessed using fixed BMI thresholds.

For example, an adult BMI of 30 kg/m² or higher is generally considered obesity.

Teenagers are still developing, so adult BMI thresholds should not simply be applied to them.

A clinician needs to consider BMI against age- and sex-specific growth references.

This allows the healthcare professional to understand whether a young person's weight is significantly outside the expected range for their stage of development.

Other factors such as:

• growth rate;

• puberty;

• family history;

• medical conditions;

• and previous weight changes

may also influence the assessment.

Who May Be Eligible for Wegovy®?

Current UK product information states that Wegovy is indicated for adolescents aged 12 years and over with:

• obesity based on age- and sex-specific BMI criteria; and

• body weight above 60 kg.

A prescriber may also consider:

• the severity of obesity;

• associated health problems;

• previous lifestyle interventions;

• mental wellbeing;

• eating behaviour;

• current medicines;

• and whether ongoing specialist follow-up is possible.

Eligibility therefore requires much more than completing an adult BMI calculator.

What Is the Wegovy® Dose for Teenagers?

For adolescents aged 12 years and over, the current UK Wegovy prescribing information uses the same gradual dose-escalation schedule as adults up to 2.4 mg once weekly.

For adolescents, weekly doses above 2.4 mg are not recommended.

This is particularly important because selected adults with obesity may now be prescribed higher Wegovy doses in some circumstances. That higher adult dosing does not apply to adolescents.

Why Is the Dose Increased Slowly?

Starting immediately on the highest dose would make gastrointestinal side effects more likely.

The gradual escalation schedule allows the body to adapt.

Common effects can include:

• nausea;

• vomiting;

• diarrhoea;

• constipation;

• abdominal discomfort;

• indigestion;

• and reduced appetite.

If gastrointestinal symptoms become significant, current product information allows dose escalation to be delayed or the dose to be reduced temporarily until symptoms improve.

Any changes should be made by the clinical team rather than by the teenager or parent independently.

How Is Wegovy® Taken?

Wegovy is injected once weekly under the skin.

It may be injected into:

• the abdomen;

• thigh;

• or upper arm.

It can be taken at any time of day and with or without food.

The injection site should be changed regularly.

Parents, carers and young people should receive appropriate instructions on how to use the injection device safely.

What Happens If a Dose Is Missed?

If a Wegovy dose is missed, current UK product information states that it can be taken as soon as possible if no more than five days have passed.

If more than five days have passed:

• skip the missed dose;

• take the next dose on the normal scheduled day;

• and then continue the usual weekly schedule.

If several doses are missed, the prescriber may consider restarting at a lower dose.

Never take additional injections to compensate for missed treatment without clinical advice.

Does Wegovy Actually Work in Teenagers?

Semaglutide has been studied in adolescents in the STEP TEENS trial.

The study included adolescents aged 12 to under 18 with obesity, or overweight plus a weight-related health condition.

Participants received semaglutide or placebo alongside a reduced-calorie diet and increased physical activity for 68 weeks.

The UK prescribing information reports that improvement in BMI with semaglutide was significantly greater than with placebo, and a greater proportion of teenagers achieved reductions of at least 5%, 10% and 15% of body weight.

These are encouraging findings, but individual results vary.

Medication does not guarantee a particular amount of weight loss.

When Is Treatment Reviewed?

Teenage weight-management treatment should have clear review points.

Current Wegovy product information states that treatment should be discontinued and re-evaluated if an adolescent has not reduced their BMI by at least 5% after 12 weeks at the 2.4 mg dose or maximum tolerated dose.

This prevents medication being continued indefinitely when it is not producing sufficient benefit.

Monitoring should also consider much more than BMI.

What Else Should Be Monitored?

For an adolescent, clinical reviews may consider:

• height;

• growth;

• BMI trajectory;

• nutritional intake;

• hydration;

• gastrointestinal symptoms;

• physical activity;

• mental well-being;

• school and social functioning;

• and obesity-related health conditions.

Teenagers are still developing, so protecting nutrition and normal development is an important part of treatment.

Does Wegovy Affect Growth or Puberty?

This is an understandable concern for parents.

In the adolescent clinical trial included in the UK product information, no effects on growth or pubertal development were identified after 68 weeks of treatment.

However, this does not remove the need for careful long-term monitoring.

Adequate nutrition remains particularly important during adolescence.

What Side Effects Can Teenagers Experience?

The type and severity of adverse effects seen in adolescent studies were broadly similar to those seen in adults.

Common GLP-1 side effects are mainly gastrointestinal and may include:

• nausea;

• vomiting;

• diarrhoea;

• constipation;

• abdominal discomfort;

• indigestion;

• and reduced appetite.

In the adolescent trial, gallstones were also reported more often in patients receiving Wegovy than placebo.

Persistent or severe symptoms should always be discussed with the clinical team.

Why Reduced Appetite Needs Careful Monitoring in Teenagers

In adults, reduced appetite is usually viewed primarily as part of the desired treatment effect.

In adolescents, clinicians also need to make sure appetite suppression does not lead to inadequate nutrition.

Teenagers require sufficient:

• protein;

• iron;

• calcium;

• vitamins;

• minerals;

• energy;

• and fluids

to support normal growth and development.

The aim is not to make a young person eat as little as possible.

The objective is healthier weight management while maintaining a balanced and nutritionally adequate diet.

Does GLP-1 Medication Replace Healthy Eating?

No.

Medication should be used alongside a healthy nutrition plan and increased physical activity.

Sustainable changes may include:

• eating balanced meals;

• reducing sugary drinks;

• increasing vegetables and fruit;

• including adequate protein;

• choosing appropriate portions;

• and limiting frequent high-calorie snacks and takeaways.

Very low-calorie diets or extreme food restriction should not be attempted without appropriate specialist supervision.

Physical Activity Still Matters

GLP-1 medication may reduce appetite, but it does not provide the wider health benefits associated with regular physical activity.

Movement can support:

• cardiovascular fitness;

• muscle health;

• bone strength;

• mood;

• confidence;

• sleep;

• and long-term weight maintenance.

Activity should ideally be enjoyable.

For teenagers, this could include:

• football;

• swimming;

• cycling;

• dancing;

• walking;

• martial arts;

• gym activity where appropriate;

• or other forms of active recreation.

Why Family Support Is Important

Teenagers rarely control their entire food and activity environment.

Parents and carers influence:

• grocery shopping;

• meal preparation;

• takeaway frequency;

• available snacks;

• travel;

• and opportunities for exercise.

Making healthy changes as a household can therefore be more effective than putting one young person on a separate diet.

It may also reduce stigma.

Instead of saying:

“You need to lose weight.”

A healthier approach may be:

“We're going to work together on eating better and being more active.”

Mental Health Needs to Be Part of Treatment

Teenagers living with obesity may experience:

• bullying;

• body-image concerns;

• anxiety;

• depression;

• social withdrawal;

• low confidence;

• or emotional eating.

Some may also have an eating disorder or develop unhealthy restriction after beginning weight-loss treatment.

A responsible service should consider these factors before prescribing.

Medication should never be used as a way to reinforce pressure to become thinner.

What If a Teenager Has Binge-Eating Symptoms?

Binge eating requires careful assessment.

Warning signs may include:

• regularly eating unusually large amounts of food;

• feeling unable to stop;

• eating secretly;

• experiencing shame after eating;

• or alternating between binge eating and extreme restriction.

A specialist mental-health or eating-disorder pathway may be needed.

Weight-loss medication should not be used to avoid addressing an underlying eating disorder.

What About Pregnancy?

Weight-loss medicines should not be used during pregnancy.

For adolescents who could become pregnant, this needs to be discussed sensitively and confidentially as part of treatment.

Semaglutide should be stopped before a planned pregnancy according to its product information.

Patients should tell their clinical team immediately if pregnancy occurs or is suspected.

Can Teenagers Use Mounjaro?

Mounjaro contains tirzepatide and is widely used for adult weight management.

However, adult availability does not mean that a medicine is automatically licensed or appropriate for adolescents.

Teenage prescribing must follow the current UK licence for the specific medicine.

Parents should never give a child or teenager medication that has been prescribed for an adult family member.

What About Oral GLP-1 Weight Loss Pills?

Again, formulations matter.

The adult Wegovy pill treatment currently offered through 24 HR Pharmacy has its own oral dosing schedule for eligible adults.

That adult tablet regimen should not be applied to adolescents simply because injectable Wegovy indicates people aged 12 and over.

Age eligibility and dosing must be established separately for each medicine and formulation.

Is Wegovy Available on the NHS for Teenagers?

This requires an important distinction between licensing and NHS recommendation.

Wegovy has a UK adolescent indication for appropriate patients aged 12 and above.

However, NICE terminated its specific technology appraisal of semaglutide for managing overweight and obesity in people aged 12 to 17 because the manufacturer did not submit evidence for the economic appraisal.

NICE therefore currently does not make a routine NHS technology-appraisal recommendation for semaglutide in this age group.

Local NHS organisations may make their own decisions where appropriate.

Are There Other GLP-1 Treatments for Teenagers?

Yes, there are other medicines in the broader GLP-1 family with adolescent indications.

The most appropriate treatment depends on current licensing, availability, medical history and specialist judgement.

Wegovy for Teenagers

Wegovy acts through the GLP-1 pathway.

The most convenient treatment is not necessarily the most suitable one.

What Are the Potential Benefits of GLP-1 Treatment for Teenagers?

For an appropriately selected adolescent, potential benefits may include:

• meaningful improvement in BMI;

• reduced hunger;

• improved portion control;

• easier adherence to healthier eating;

• reduced obesity-related health risks;

• better mobility;

• and improved quality of life.

If weight-related conditions such as high blood pressure or metabolic problems are present, weight improvement may also contribute to better long-term health.

What Are the Limitations?

GLP-1 medication is not a perfect solution.

Potential limitations include:

• gastrointestinal side effects;

• injections;

• ongoing monitoring;

• cost and access;

• appetite returning after treatment stops;

• the need for long-term lifestyle change;

• and the possibility that treatment does not produce sufficient benefit.

Medication may also be unsuitable because of medical or psychological factors.

What Happens When GLP-1 Medication Is Stopped?

Appetite can increase again after GLP-1 treatment is withdrawn.

This means long-term success depends partly on the habits and support developed during treatment.

Young people may need continued help with:

• balanced meals;

• physical activity;

• portion awareness;

• sleep;

• emotional eating;

• and maintaining progress.

Treatment should therefore include planning for life beyond medication.

How Should Parents Talk to Their Teenager About GLP-1 Medication?

Try to frame the discussion around health rather than appearance.

Useful areas to focus on include:

• energy;

• mobility;

• sleep;

• long-term health;

• confidence;

• and feeling physically well.

Avoid presenting medication as something the teenager needs because their body looks wrong.

The young person should also have an opportunity to:

• ask questions;

• express concerns;

• understand potential benefits and risks;

• and participate meaningfully in treatment decisions.

How 24 HR Pharmacy Can Help

At 24 HR Pharmacy, we provide a specialist adolescent obesity and healthy weight service for young people aged 12 and over through our Family Healthy Weight Programme.

Childhood and adolescent obesity requires a different approach from adult weight management. Rather than simply providing access to medication, our service brings together a multidisciplinary clinical team, including a specialist obesity prescriber, dietitian and paediatrician, to assess the young person as a whole and develop an individualised treatment plan.

Specialist Multidisciplinary Assessment

Every young person entering the programme receives an age-appropriate assessment. Depending on their individual circumstances, our specialist team considers factors including:

• age, height and weight;

• age-adjusted BMI and growth history;

• physical health and obesity-related conditions;

• current and previous medicines;

• previous weight-management support;

• nutrition and eating patterns;

• sleep and physical activity;

• family and lifestyle factors;

• and psychological wellbeing.

The involvement of a paediatrician helps ensure weight is considered alongside growth, development and wider physical health, while our dietitian provides nutritional guidance appropriate for a growing child or teenager.

Specialist Obesity Prescriber

Our specialist obesity prescriber reviews whether medical treatment should form part of the young person's overall care plan.

Medication is not automatically recommended simply because an adolescent meets a particular weight or BMI threshold. The prescriber considers the young person's health, age, previous interventions, potential risks and whether a treatment is licensed and clinically appropriate for their circumstances.

Appropriate Treatment Selection

Where prescription weight-management medication is considered appropriate, our multidisciplinary team helps ensure that the treatment selected is suitable for the young person's age, health and individual clinical needs.

Medication is used as part of a broader healthy-weight programme rather than as a standalone solution. Treatment can be combined with dietetic support, family-based lifestyle changes, appropriate physical activity and ongoing clinical monitoring.

Ongoing Family Support

Our Family Healthy Weight Programme is designed to involve and support parents and carers as well as the young person.

The aim is to create sustainable changes within the home rather than placing responsibility for weight management entirely on the child.

Regular follow-up also allows our clinical team to monitor areas such as:

• growth and development;

• nutritional intake;

• treatment response;

• side effects where medication is used;

• physical health;

• lifestyle progress;

• and overall wellbeing.

This specialist, multidisciplinary approach allows 24 HR Pharmacy to provide dedicated adolescent obesity care rather than simply adapting an adult weight-loss service for younger patients.

Frequently Asked Questions

Can a 12-year-old use a GLP-1 weight loss medicine?

Some GLP-1 medicines have UK indications from age 12 in appropriately selected patients.

Wegovy is licensed for adolescents aged 12 and above with obesity and a body weight over 60 kg.

What is the Wegovy starting dose for teenagers?

The starting dose is 0.25 mg once weekly for four weeks.

What is the maximum Wegovy dose for teenagers?

The recommended maintenance dose is 2.4 mg once weekly or the maximum tolerated dose.

Weekly doses above 2.4 mg are not recommended in adolescents.

Is Wegovy 7.2 mg suitable for teenagers?

No.

The higher 7.2 mg dose is an adult weight-management option in selected circumstances. Current UK prescribing information states that adolescents should not receive doses above 2.4 mg weekly.

How long before you know if Wegovy is working?

For adolescents, current prescribing information says treatment should be re-evaluated if BMI has not decreased by at least 5% after 12 weeks on the 2.4 mg or maximum tolerated dose.

Can teenagers use the Wegovy pill?

The oral Wegovy service currently marketed by 24 HR Pharmacy is an adult treatment pathway. Its adult tablet dosing should not be transferred to adolescents.

A teenager requires a medicine and formulation specifically considered appropriate for their age.

Does Wegovy affect puberty?

In the 68-week adolescent trial reported in UK prescribing information, no effects on growth or pubertal development were identified.

Does a teenager still need to exercise while taking Wegovy?

Yes.

Wegovy is licensed as an addition to a reduced-calorie diet and increased physical activity rather than a replacement for either.

Is GLP-1 medication safe for every teenager with obesity?

No.

Eligibility and safety must be assessed individually.

Medical history, eating behaviour, mental health, other medicines, nutrition and obesity severity can all influence whether treatment is appropriate.

Can parents order GLP-1 medication for their teenager?

A parent cannot establish eligibility simply by requesting medication.

The young person needs an appropriate clinical assessment, and prescription treatment should only be issued when the prescriber determines that it is safe and suitable.

Final Thoughts

GLP-1 weight loss medication can help some teenagers living with obesity, but it should never be viewed as a simple or cosmetic weight-loss solution.

For adolescents aged 12 years and over, injectable Wegovy® may be considered where the young person has obesity, weighs more than 60 kg and meets the wider clinical criteria.

The correct adolescent Wegovy schedule is:

• 0.25 mg once weekly for weeks 1–4

• 0.5 mg once weekly for weeks 5–8

• 1 mg once weekly for weeks 9–12

• 1.7 mg once weekly for weeks 13–16

• 2.4 mg once weekly or the maximum tolerated dose from week 17 onwards

Doses above 2.4 mg weekly are not recommended for teenagers.

Medication should sit within a wider programme that protects:

• healthy growth;

• nutrition;

• physical health;

• mental wellbeing;

• and sustainable family habits.

Through a specialist adolescent weight-management pathway, 24 HR Pharmacy can help families understand whether GLP-1 treatment may be appropriate, arrange careful clinical assessment and support eligible teenagers throughout treatment.

The aim is not simply to reduce a number on the scales.

It is to improve health safely and sustainably while supporting a young person's development, confidence and long-term wellbeing.